RhyTab 7.5mg Tablet

RhyTab 7.5mg Tablet is a medication that contains Ivabradine as its active ingredient. Ivabradine is a selective inhibitor of the I(f) current in the sinoatrial (SA) node, leading to a reduction in heart rate. It is commonly prescribed to manage certain heart conditions.

Active Ingredient:

• Ivabradine

Uses:

RhyTab 7.5mg Tablet is primarily used for the following purposes:

1. Chronic Stable Angina: It is indicated to reduce the risk of hospitalization for worsening heart failure in patients with stable, symptomatic chronic heart failure.
2. Heart Failure: To reduce the risk of hospitalization for worsening heart failure in patients with stable, symptomatic chronic heart failure with reduced ejection fraction.

Mechanism of Action: Ivabradine works by specifically inhibiting the I(f) current in the SA node of the heart, leading to a reduction in the heart rate without affecting other cardiac parameters.

Dosage and Administration: The dosage of RhyTab 7.5mg is determined by the treating healthcare provider based on the patient’s medical condition. It is usually taken orally with meals.

Precautions:

1. Bradycardia: RhyTab may cause bradycardia (slow heart rate), and caution is advised in patients with pre-existing bradycardia.
2. Atrial Fibrillation: It is not recommended for use in patients with atrial fibrillation.
3. Liver Impairment: Adjustments in dosage may be necessary in patients with moderate to severe liver impairment.

Side Effects:

Common side effects may include bradycardia, luminous phenomena (visual brightness), and atrial fibrillation.

When Not to Use:

RhyTab 7.5mg Tablet should not be used in individuals with a known allergy to Ivabradine, patients with resting heart rates below 60 beats per minute before treatment, or in those with severe liver impairment.

Note: This information provides a general understanding of RhyTab 7.5mg and its uses. However, it is not a substitute for professional medical advice. Patients should consult their healthcare provider for personalized guidance, considering individual health conditions and needs.